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Abstract
Background
Recent advances in obesity research suggest that BAT activity, or absence thereof, may be
an important factor in the growing epidemic of obesity and its manifold complications. It is
thus important to assess larger populations for BAT-activating and deactivating factors.
18FDG-PET/CT is the standard method to detect and quantify metabolic BAT activity, how-
ever, the manual measurement is not suitable for large studies due to its time-consuming
nature and poor reproducibility across different software and devices.
Methodology/Main Findings
In a retrospective study, 1060 consecutive scans of 1031 patients receiving a diagnostic
18FDG-PET/CT were examined for the presence of active BAT. Patients were classified
according to a 3-tier system (supraclavicular, mediastinal, infradiaphragmatic) depending
on the anatomical location of their active BAT depots, with the most caudal location being
the decisive factor. The metabolic parameters (maximum activity, total volume and total gly-
colysis) were measured on a standard PET/CT workstation. Mean age of the population
was 60±14.6y. 41.61% of patients were female. Metabolically active BAT was found in 53
patients (5.1%). Female, younger and leaner patients tended to have more active BAT,
higher metabolic activity and more caudally active BAT. In total, 15 patients showed only
supraclavicular, 27 additional mediastinal, and 11 infradiaphragmal activity. Interestingly,
the activation of BAT always followed a cranio-caudal gradient. This anatomical pattern cor-
related with age and BMI as well as with all metabolic parameters, including maximum and
total glycolysis (p<0.001).
Conclusion
Based on our data we propose a simple method to grade or quantify the degree of BAT
amount/activity in patients based on the most caudally activated depot. As new modalities
for BAT visualization may arise in the future, this system would allow direct comparability
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with other modalities, in contrary to the PET-metrics, which are restricted to 18FDG-PET/
CT.
Introduction
Obesity has expanded as an epidemic in the developed and developing world, with the WHO
estimating an approximate of 600 million people being obese and more than 1.9 billion adults
belonging to the overweight category [1–4]. It is defined as the “abnormal or excessive fat accu-
mulation that may impair health” [1] due to long-term positive energy balance, usually caused
by reduced levels of physical activity/exercise and/or high consumption of energy-dense foods.
Obesity has been associated with several co-morbidities including type II diabetes, cardiovascu-
lar disease, musculoskeletal disorders such as osteoarthritis and some types of cancer [5].
Therefore, prevention and treatment of obesity is of high importance, however lifestyle changes
exert only modest results and do not seem to be successful in the long term [6]. Additionally,
pharmacological approaches are limited and ineffective. In fact, several anti-obesity drugs have
been developed, but not been approved due to severe side effects [7]. It is thus important that
novel, pharmacological and non-pharmacological anti-obesity treatments are developed in
order to reduce the burden of obesity.
The adipose organ (reviewed in detail by Rosen et al. [8]) is a multi-depot endocrine organ
that can be macroscopically divided into two different types: the white and the brown adipose
tissue, based on the predominant form of adipocyte. White adipose tissue (WAT) constitutes
the major storage depot of excess energy in the form of triacylglycerols (TGs) in the liposomes
of white adipocytes as well as an important endocrine organ. On the contrary, the main func-
tion of brown adipose tissue (BAT) is non-shivering thermogenesis (i.e. heat production) in
brown adipocytes. The protein responsible for this particular function of brown adipose tis-
sue–constituting at the same time the only brown adipose tissue specific marker in humans–is
uncoupling protein 1 (UCP1). UCP1 is located in the inner mitochondrial membrane and dis-
sipates the proton (H+) gradient formed as a result of oxidative phosphorylation, which is nor-
mally used for phosphorylation of ADP, thus uncoupling mitochondrial respiration from ATP
production. The mitochondrion is thus running “out of gear” and the energy dissipates in heat.
A third form of fat cell, the brite (“brown-in-white”) or beige adipocyte has been character-
ized microscopically and is still being studied extensively in vitro and in vivo. [9]. To date,
brown fat is indistinguishable from brite fat in FDG-PET/CT as no activity threshold or spe-
cific anatomic locations in humans have been established. In the following sections we shall
henceforth use BAT as a synonymous abbreviation for brown and brite fat.
Many mammals like the hedgehog or mouse use BAT for their thermostasis during hiberna-
tion [10]. In humans, it was long believed that only neonates and young children have metabol-
ically active BAT. Even though in autopsy series BAT was found in adults [11], the evidence in
favor of BAT being metabolically active in adults [12] was largely ignored and the dogma per-
sisted, that BAT rapidly loses its function after childhood. Thanks to the ability of 18FDG-PET/
CT to match glycolysis with exact anatomical location, metabolic activity in BAT in adults was
first visualized by Hany et al. in 2002 [13].
Since then in depth analyses in adult human studies were performed [14–16], and there has
been a growing interest in brown adipose tissue as a novel therapeutic approach to activate
energy dissipation in BAT in order to aid and accelerate weight-loss. In the last few years a host
of human studies have been reported demonstrating the correlation of (absence of) active BAT
with multiple parameters linked to obesity and the development of metabolic disorders. It has
been shown that gender, age, BMI as well as central obesity have an influence on the presence
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of active BAT [17]. Furthermore, in experimental studies, several factors have been discovered
that either activate or deactivate BAT. For example, it was shown that physical application of
cold [18] or oral intake of bile acids [19] or selective β3-agonists [20] can activate brown fat
[15] whereas propranolol, a non-selective β-blocker, pharmacologically blocks the activation of
BAT [21].
From the first description of active BAT in adult humans in 2002 [13], 18FDG-PET/CT has
played not only a crucial role in subsequent studies [14–17, 22–25], but has become the de-
facto “gold standard” for detecting active BAT. Indeed, 18FDG-PET/CT is ideal to identify new
and to discern strongly from weakly activating or inhibiting factors and to quantify the inten-
sity of BAT activation. Through the combination of PET and CT imaging metabolic activity
can not only be precisely matched to the anatomic location, but also accurately measured in
individual regions of the 3D volumetric dataset. Albeit accurate, this manual measurement is
also very time-consuming and results may not be comparable across different devices. It is thus
unsuitable for large, prospective, multi-center trials.
In the present retrospective study we examined the influence of known BAT-activating fac-
tors in relation to glucose metabolism (i.e. intensity of activation) using various quantitative
PET metrics, as well as anatomic location and distribution patterns of the activated depots to
find a simple and robust method for quantification of BAT activity.
Materials and Methods
Patient Population
This study was approved by the local ethics committee of the University of Zürich, who waived
the need for informed consent. All patients referred for a diagnostic 18FDG-PET/CT from
November 2014 to January 2015 at the University Hospital of Zürich were included. No
patients were excluded.
Pre-scan fasting blood glucose level of all patients with active BAT was obtained post hoc
from the patient records.
Image Acquisition
All patients were scanned on a dedicated PET/CT machine (GE Healthcare DSTX, 16-or
64-slices CT, 7–8 frames, frame time 1.5 or 2 minutes). Fasting for 6 hours prior to the study,
including sweetened beverages and chewing gum, was mandatory. Blood glucose was measured
prior to the FDG-injection and had to be below 7 g/l [26]. Patients received approximately 4
MBq 18F-FDG per kilogram bodyweight, followed by a 60 ± 5 min. uptake period. Afterwards,
a low-dose, attenuation correction CT scan was acquired (100–120 kV, approx. 80 mA), fol-
lowed by the PET scan from mid-thigh to the vertex of the skull.
Image Analysis
Images were analyzed on state-of-the-art dedicated workstation for PET/CT image reading
(AW version 4.6, GE Healthcare DSTX) by one reader dually specialized in radiology and
nuclear medicine. The activity of BAT was measured in standardized uptake values (SUV [g/
ml]), a measure commonly used in PET/CT in the clinical routine.
All patients were screened for the presence of active BAT using a 3D maximum intensity
projection (MIP) image of the PET scans. In a MIP image, the volumetric image data is reduced
to a 2D planar projection, and only the voxel with the highest value (i.e. maximum metabolic
activity) is used for the pixel of the projected image. The PET and CT images were subse-
quently electronically co-registered and digitally fused, with a colorized PET image overlaying
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the CT image. The color scale (“Perfusion”, GE Healthcare DSTX) was set between SUV 0–6 g/
ml for visual analysis. In all positive or ambiguous cases, the fused PET/CT series was used for
a definitive decision. BAT was considered metabolically active, when a metabolically active
area in the MIP image could be appreciated, that subsequently matched to a fat-density area in
the CT image (-250 to -50 Hounsfield Units).
Subsequently, in all patients with active BAT the maximum and mean SUV (SUVmax,
SUVmean), the total fat gylcolysis (TFG; counterpart to the normally used PET-metric “Total
lesion glycolysis TLG”) and metabolically active fat volume (MFV; counterpart to “Metabolic
tumor volume MTV”) of the BAT were measured. The cut-off for TFG and MFV was set at
2.5 g/ml. In cases with a SUVmax below 2.5, the background signal in white fat was measured
and used as a cut-off. Patients were classified according to a 3-tier system depending on the
anatomical location of their active BAT.
Statistical Methods
Statistical analysis was done with R version 3.2.1 (R Core Team (2015). R: A language and envi-
ronment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
URL http://www.R-project.org/). Graphs/plots were produced with the ggplot2 package [27].
Due to the small proportion of BAT-positive patients compared to BAT-negative patients, den-
sity plots were used for the distribution of age and BMI as opposed to conventional histograms.
The remaining tests were performed using native R functions. We used descriptive analysis
(mean, standard deviation, median) for all relevant continuous parameters, regression analysis
with a general linear model for anatomical distribution to BMI, temperature or age, as well as
Student's t-test for continuous variables and Fisher's exact test (Presence of BAT—age / BMI /
sex / temperature, sex—metabolic activity / anatomical distribution / blood glucose). A p-value
of< 0.05 was considered statistically significant; Bonferroni correction was used where
appropriate.
Results
Identification of BAT positive patients
To identify patients with positive BAT signatures we retrospectively analyzed 1060 scans of
1031 patients, scanned from November 2014 to January 2015 at our institution. The mean
FDG activity used in the PET-CT scan was 4 MBq per kg bodyweight, mean time between
application and scan was 61 ± 9 minutes. The mean age of the analyzed individuals was 60
years (median 62 y, range 9–97 y, ± 14.6 y). Males accounted for 59.4% of the population,
female patients for 40.6%, respectively. The mean BMI of the studied subjects was 24.9 ± 4.8
kg/m2. The female subjects included in the study were slightly but significantly younger (3.4
years) and had a lower BMI (4.3 points) than males (p< 0.001). To correlate BAT activity with
outside temperature, we acquired the average temperature for the day of the scan from a com-
mercial provider (MeteoGroup Ltd., Berlin, Germany). Their closest weather station is located
about 800 m from the hospital, providing a good approximation of the daily temperatures at
the site of the examination. The mean temperature was 3.9 ± 3.6°C, with a maximum tempera-
ture of 11.2°C during the three-month-period.
In the FDG-PET scan, BAT with a metabolic activity (SUVmax) above 2.5 g/ml was consid-
ered as positive. To avoid false positives of other activity (e.g. muscles, lymph nodes), the pre-
cise anatomic location of the metabolic activity was always verified on the digitally fused PET/
CT slices.
Metabolically active BAT was found in 53 patients (5.1%) and there were no patients with
active BAT on more than one scan in the given time period. Mean age in BAT-positive patients
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was 49.32, (median 49, range 17–77). We identified 17 male and 37 female subjects with posi-
tive BAT signature and as reported previously [14, 16, 17, 24] female patients were significantly
more likely to show metabolically active BAT than male patients (estimated odds ratio of 3.62,
p< 0.001) independent of age (p = 0.24) (Fig 1A). Similarly, we observed a significant shift in
age (Fig 1B) and BMI (Fig 1C) distribution, indicating that BAT activity is inversely correlated
with both parameters. Similarly to the whole population, female BAT-positive patients showed
a lower BMI compared to males (19.6 vs. 23.66, p = 0.02), and we did not observe any differ-
ence in mean daily temperature for males and females (p>0.6). The details of the cohort are
summarized in Table 1.
Patterns and Activity of BAT
In our 53 BAT-positive subjects we observed an average SUVmax of 7.8 ± 4.4, an average SUV-
mean of 3.12 ± 0.58 and average TFG of 12782 ± 98172 and an average MFV of 76.2 ± 101.3 cm
3
(± SD), respectively. From our clinical experience, we noticed an activation of BAT in distinct
anatomical locations. We thus classified the distribution of active BAT according to a three-tier
system, with three easy-to-identify main depots: Supraclavicular (including axillary and
nuchal), Mediastinal and Infadiaphragmal (Fig 2).
Fig 1. Differences between the two cohorts. a) Sex difference: Stacked bar plot depicting the top 15% percent of the overall population, showing the
higher incidence (OR = 3.62) of positive BAT in females compared to males. b) Age and c) BMI difference of the BAT-positive cohort. Density plots
showing the shift of age and BMI from the overall population to the BAT-positive cohort (blue), who were found to be significantly younger and lighter.
doi:10.1371/journal.pone.0149458.g001
Table 1. Cohort details.
Category Overall BAT-Positive BAT-Negative
N 1060 53 1007
Sex (Male/Female) 631 / 429 16 / 37 † 615 / 392
Age (Years) 60.04±14.65 49.32±15.54 † 60.6±14.39
Height (m) 1.71±0.09 1.67±0.07 † 1.71±0.09
Body Weight (kg) 72.68±16.19 60.51±12.35 † 73.32±16.12
BMI (kg/m2) 25.16±6.23 20.86±4.77 † 25.38±6.21
Temperature (°C) 3.88±3.58 3.07±3.43 3.92±3.58
Indicated are the numbers of cases and continuous parameters from the whole population as well as separated by BAT-activity as means ± SD. Highly
signiﬁcant differences, i.e. p < 0.001, in the BAT-positive cohort compared to the overall population are marked with a dagger sign (†)
doi:10.1371/journal.pone.0149458.t001
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Of the 53 patients with active BAT, 15 showed only supraclavicular, 27 additional mediasti-
nal, and 11 infradiaphragmal activity. (Fig 2B). The activation of BAT always followed a strictly
cranio-caudal gradient, i.e. no patient had active BAT in the abdomen without active BAT in
the mediastinum and supraclavicular area, and there were no cases with active BAT in the
mediastinum without supraclavicular activation as well. Furthermore, BAT total volume, total
fat glycolysis and SUVmax correlated significantly with the localization of BAT (Fig 3), suggest-
ing that the further caudally the active BAT depots are observed, the more BAT gets recruited
and the higher is the maximum BAT activity as well as the total BAT glycolysis.
Interestingly, these findings also correlated with different metabolic parameters as indicated
in Fig 4. For example we could show that not only BMI correlated with BAT localization
Fig 2. Morphologic Patterns of BAT. a) Schematic drawing of the different depots, some of which were summarized as indicated by the coloration into the
three categories c) supraclavicular d)mediastinal and e) infradiaphragmatic. b) Showing the total number of BAT-positive subjects grouped by the most
caudally active depot of either supraclavicular (including axillary and nuchal), mediastinal or infadiaphragmal BAT. c-e)Coronal MIP PET images (left) and
fused PET/CT slices (right) of representative subjects in the according category. All pictures also show variable glucose uptake of the liver, intestines and
myocardium as well as strong emissions from the renal pelvis, the latter being concentrated 18FDG breakdown products excreted through the urine. This can
be appreciated in the fused d) image, where the true BAT activity is located in a fat depot on the patient’s left side (right side on the picture) adjacent to the
first lumbar vertebra.
doi:10.1371/journal.pone.0149458.g002
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(p< 0.05; Fig 4A), a similar correlation was observed for age (p< 0.01; Fig 4B) suggesting that
younger and leaner patients tended to have more active BAT and showed more BAT in the
infradiaphragmatic region. In contrast to BMI and age, no correlation with the external tem-
perature could be established (p = 0.17; Fig 4C and Table 2). However, the difference of the
mean temperature between no activation, and mediastinal and infadiaphragmatic activation
combined was significant (p<0.0125).
At very cold temperatures (< -2°C), only three cases of active BAT were observed, two with
supraclavicular type, i.e. “weak” activation (SUVmax 3.5, 2.9), and one with supraclavicular,
mediastinal and infradiaphragmatic, i.e. “strong” activation (SUVmax 10.9). Within the differ-
ent morphological categories, no significant correlations for age, BMI or temperature could be
found, as can be appreciated in the scatterplots (Fig 4A and 4B): While the different colors (=
anatomic locations) form notable clusters, within each color/location no pattern can be found.
Fasting blood glucose levels were not significantly different between the different morpho-
logical categories. There was a tendency for the fasting blood glucose to correlate weakly with
the BMI, though it did not reach statistical significance in our sample (p = 0.09).
Discussion
The propagating epidemic of obesity in industrialized as well as developing nations, and all of
the entailed complications (diabetes, arterial hypertension and cancer, to name only a few [6]),
have led to enormous efforts in clinical and laboratory research in the past decades to under-
stand the function of different fat tissues in its pathogenesis [28]. The description of metaboli-
cally active BAT in 2002 and the subsequent studies demonstrating the presence of brown fat
by molecular analysis [13–16, 18] have sparked a wide interest in this tissue. Although semi-
automatic measurement of FDG-activity can be done in cancer patients [29], in the case of
BAT it is very prone to false positive measurements, since physiologic brain or heart activity or
malignant tumor activity could not be distinguished from BAT. Thus, the current method of
measuring BAT activity implicates manually placing regions of interest in the PET/CT scan
(SUVmax), and manually segmenting the picture (TFG, MFV) by cropping other metabolically
active tissues like the myocardium, liver or skeletal muscles. This process is neither suitable for
larger studies due to its tedious, time-consuming nature, nor for multi-center trials, due to the
lack of harmonized PET quantification due to institution and scanner specific imaging and
reconstruction algorithms [30], as well as potential inter-operator differences in the manual
Fig 3. Quantification of glycolysis in the different depots. A clear increase of all three metabolic PET-parameters MFV, TFG and SUVmax, from the
supraclavicular depots to the more caudally located infradiaphragmatic depots can be appreciated.
doi:10.1371/journal.pone.0149458.g003
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segmentation. Although different, easy-to-identify anatomical locations of BAT depots have
been described, there has yet to be any attempt to use them for a simpler grading system of
BAT activation.
Fig 4. Differences in BAT activation between individuals and categories. The first column depicts the total fat glycolysis (TFG) in relation to BMI (a), age
(b) and external temperature (c). As can be guessed by the visual impression of the scatter plots, no clear correlation between either of the factors and the
TFG could be established. In the second column however, the same data is shown and instead of using the metabolic activity, it is simply ordered by the
morphological type of activation, showing clearly more activated depots with lower BMI, age and temperature. The dashed lines in (a) and (b) represent the
significant linear correlation (p > 0.05), the asterisk (*) in (c) marks the only statistically significant difference (p<0.0125) in absence of a linear correlation.
doi:10.1371/journal.pone.0149458.g004
Grading System for Brown Fat Activity
PLOS ONE | DOI:10.1371/journal.pone.0149458 February 22, 2016 8 / 12
Our inclusion threshold SUV of 3 g/ml was slightly higher than in most previous studies
(SUV of 1–2 g/ml) to reduce the possibility of false positives. In our population, we found a
BAT incidence of 5.1%, which is in concordance with previously reported studies (e.g. 5.4%
from Cypess et al. [14]). Furthermore, in line with previous studies [15–18, 22, 24, 31, 32] we
identified significantly more females, as well as younger and leaner (i.e. lower BMI) patients in
the BAT positive cohort than in the whole population.
In our set of analysis we did not observe a significant difference in the daily temperature
between the BAT positive and negative patients. This is most probably due to the fact that we
deliberately chose the three cold winter months November to January with a mean temperature
lower than 4°C and a maximum of 11.2°C for our retrospective study in order to obtain a
higher prevalence in the studied population, as previously reported [14].
In previous PET and autopsy studies, in total 18 anatomical locations of active BAT have
been reported [11, 33]. Their categorization is based on the depth of the depot, with the subcu-
taneous ones representing the most superficial ones, and the vicinity to relevant anatomical
structures like vessels, viscus or parenchymatous organs.
For practical purposes, we summarized the many different depots in three categories: Supra-
clavicular, mediastinal and infradiaphragmatic. The names describe the visually most accentu-
ated depot: The supraclavicular category contains the axillary depot, which is strictly
anatomically speaking located below the clavicles (infraclavicular). We still used the name
“supraclavicular” in spite of a more accurate label like “supramammillary extrathoracal”
because it is simpler and commonly used in the existing literature. While a finer graduation is
definitely possible, e.g. dividing the nuchal from the supraclavicular depot, more categories
(and thus less cases per category) make it more difficult to obtain an applicable grading system.
Furthermore, some of the described depots such as the subcutaneous depot in the anterior
abdominal wall, are known to be inactive after the first decade of life [11].
A large advantage of an anatomy-based grading system is the direct applicability to other
imaging modalities. For example, we would be able to compare study data across different
PET-tracers in case a new, more specific PET tracer would replace the fairly unspecific 18FDG
as the standard in detecting BAT in the future. This direct comparison is not possible with the
Table 2. Morphological differences in BAT activity.
Pattern Supraclavicular Mediastinal Infradiaphragmatic
N 15 27 11
Sex (Male/Female) 7 / 8 8 / 19 1 / 10
Age (Years) 44.8±14.02 52.78±14.8 47±18.51
Height (m) 1.68±0.08 1.67±0.06 1.67±0.07
Body Weight (kg) 61.13±16.16 61.26±10.42 57.82±11.63
BMI (kg/m2) 22.06±6.01 20.85±3.99 19.22±4.5
Temperature (°C) 4.13±4.41 2.6±2.95 2.75±3
Fasting blood glucose (mmol/l) 4.9±0.6 5.1±0.8 4.9±0.6
SUVmax 5.01±2.47 7.22±3.39 12.93±4.61
TFG 36595±45133 217268±347291 648555±359665
MFV (cm3) 16.26±23.45 65.71±97.83 183.86±96.41
Shown are the differences in demographic data and mean daily temperature (upper part), as well as the metabolic parameters (lower part), between the
cohorts with the different BAT-activation patterns. All metabolic PET-parameters showed a signiﬁcant correlation with the anatomical activation pattern
(p < 0.001).
doi:10.1371/journal.pone.0149458.t002
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standard PET-metrics. The SUV and its derived SUVmax, TFG and MFV are always tracer-spe-
cific, in addition to the problems in precise quantification discussed above.
Another advantage is the abovementioned timesaving aspect of being able to directly grade
BAT-activity in the standard picture archiving and communication (PACS) system. Whole-
body PET/CT-scans consist of large amounts of image data, the transfer of which to a separate
workstation alone will typically take between 5 and 10 minutes at current network speeds.
Manual SUV measurement would generally take at least another 5 minutes, semi-automatic
measurement by specifying a SUV threshold [29] is substantially faster but also very prone to
false positive activity eg. in the myocardium, liver or skeletal muscle. In contrast, retrieving the
images in the PACS software and anatomical grading can be achieved in under one minute.
The obvious correlation between more depots activated and more metabolically active vol-
ume could easily be established. Furthermore, the total glycolysis as well as maximum activity
also increased, the more (i.e. further caudally) depots were activated. This is an interesting find-
ing, which could be explained by several mechanisms. On the one hand it is possible that the
depots differ in β3 adrenergic receptors density [20], thus altering their propensity to be acti-
vated. Furthermore, it is possible that either the innervation varies between individuals or gen-
eral differences in sympathetic output patterns lead to the different activation patterns.
Since this is a retrospective study in a collective of mostly non-healthy patients, further pro-
spective trials in healthy subjects are warranted to investigate these questions. Moreover, in a
prospective trial the correlation with more biomarkers for example in blood or small tissue
samples would be possible.
To summarize, our results confirm that BAT activation is observed especially in females
and in younger, leaner patients. Furthermore they also confirmed the hypothesis that the
sequential cranio-caudal (“top-down”) activation correlates with all the quantitative PET
parameters for BAT activity, and thus might be used as a simple and robust grading system for
BAT activation instead of manually or semi-automatically performed, quantitative PET
measurements.
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